Clinical Complications

Aortic Stenosis: Complications & Clinical Risks

Aortic stenosis is narrowing of the aortic valve opening, restricting blood flow from the heart. It causes exertional chest pain, syncope, and heart failure; valve replacement is required for severe symptomatic disease.

Overview of Major Complications

Cardiovascular conditions carry a significant burden of systemic complications affecting multiple organ systems. The heart's central role in circulation means that impaired cardiac function can cause downstream damage to the kidneys, brain, lungs, and peripheral vasculature. Major complications include acute myocardial infarction, ischaemic stroke, systemic thromboembolism, and progressive heart failure requiring advanced device therapy or transplantation. The interplay between cardiac dysfunction, neurohormonal activation, and end-organ hypoperfusion creates cascading complication cycles that worsen prognosis when not promptly managed.

Early Complications

  • ⚠Acute decompensated heart failure — sudden worsening of breathlessness, fluid overload, reduced cardiac output
  • ⚠Acute coronary syndrome — plaque rupture leading to unstable angina or myocardial infarction
  • ⚠New-onset atrial fibrillation — rapid ventricular rate, haemodynamic compromise, embolic risk
  • ⚠Hypertensive urgency or emergency — severely elevated BP with or without end-organ damage
  • ⚠Acute pericarditis — chest pain, pericardial rub, risk of tamponade if effusion develops
  • ⚠Ventricular arrhythmias — ventricular tachycardia or fibrillation causing haemodynamic collapse

Long-Term Complications

  • →Chronic kidney disease — 30–50% of heart failure patients develop CKD from reduced renal perfusion
  • →Ischaemic stroke and transient ischaemic attacks — risk 3–5× higher in atrial fibrillation
  • →Peripheral arterial disease — claudication, critical limb ischaemia, amputation risk
  • →Pulmonary hypertension — secondary to chronic left heart failure, causes right ventricular strain
  • →Cognitive impairment and vascular dementia — from repeated cerebral hypoperfusion or microemboli
  • →Cardiac cachexia — muscle wasting and malnutrition in advanced heart failure
  • →Sudden cardiac death — most common cause of mortality in ischaemic cardiomyopathy
  • →Refractory heart failure — NYHA Class IV with hospitalisation burden and limited options

Emergency Complications

Immediate clinical action required

  • ✕Acute MI (STEMI/NSTEMI) — requires emergency revascularisation within 90 minutes (PCI)
  • ✕Ventricular fibrillation and cardiac arrest — immediate defibrillation required
  • ✕Acute pulmonary oedema — oxygen, diuretics, vasodilators, non-invasive ventilation
  • ✕Aortic dissection — immediate surgical assessment; haemodynamic instability is life-threatening
  • ✕Cardiac tamponade — emergency pericardiocentesis for haemodynamic compromise
  • ✕Complete heart block — temporary pacing required; may need permanent pacemaker

What Increases Complication Risk

  • ↑Uncontrolled hypertension (SBP >160 mmHg) — accelerates end-organ damage
  • ↑Diabetes mellitus — doubles cardiovascular complication risk; promotes nephropathy and neuropathy
  • ↑Active smoking — strongly promotes plaque instability and thrombosis
  • ↑Non-adherence to anticoagulation, antiplatelet, or statin therapy
  • ↑Obesity (BMI >30) — increases cardiac workload, promotes inflammation and dyslipidaemia
  • ↑Left ventricular ejection fraction <35% — high risk of sudden death and progressive failure
  • ↑Concurrent CKD or anaemia — amplifies cardiovascular morbidity

What Reduces Complication Risk

  • ↓Guideline-directed medical therapy (beta-blockers, ACE inhibitors, ARBs, SGLT2 inhibitors)
  • ↓Optimal BP control (<130/80 mmHg) — reduces stroke and CKD progression
  • ↓Anticoagulation in AF (NOAC or warfarin) — reduces stroke risk by ~65%
  • ↓ICD implantation in EF <35% — reduces sudden cardiac death risk by 30%
  • ↓Cardiac rehabilitation — reduces rehospitalisation and improves functional capacity
  • ↓Smoking cessation — reduces coronary event risk by 30–50% within 1–2 years

When Urgent Reassessment is Needed

The following signs may indicate a new or worsening complication requiring prompt clinical evaluation:

  • ◆Sudden severe chest pain, pressure, or radiation to jaw/arm — possible acute MI
  • ◆Acute breathlessness at rest or inability to lie flat — pulmonary oedema
  • ◆Syncope, near-syncope, or palpitations with haemodynamic compromise
  • ◆New focal neurological deficit — possible cardioembolic stroke
  • ◆Severe leg pain with pallor, pulselessness, or coldness — acute limb ischaemia
  • ◆Sudden worsening of symptoms despite medication compliance — reassess immediately

Special Populations

Elderly: polypharmacy risk, orthostatic hypotension, higher frailty score increases procedural risk; cautious initiation of diuretics and beta-blockers
Diabetes: early SGLT2 inhibitor use is cardio-renal protective; tight glucose control reduces microvascular complications
Women: atypical MI presentations (nausea, fatigue, jaw pain) lead to diagnostic delays; sex-specific risk calculators recommended
CKD patients: dose adjustment of cardiac medications essential; contrast nephropathy risk with angiography

Related Clinical Pages

Treatment & Management

Evidence-based treatment pathway, medications, and escalation criteria

Prognosis & Outlook

Long-term clinical outlook, improving and worsening outcome factors

Differential Diagnosis

Conditions that mimic Aortic Stenosis — distinguishing features & tests

Aortic Stenosis Overview

Symptoms, causes, and general condition overview

Similar Conditions With Different Risk Profiles

These conditions share overlapping symptoms with Aortic Stenosis but have distinct complication patterns — understanding the differences is clinically important.

Aortic Stenosis vs Heart FailureCompare →

Concerned about Aortic Stenosis?

Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.

Start Free AI Analysis →

Medical References

Content on this page is informed by evidence-based clinical sources including: